SLC35A2 and focal epilepsy: Broadly, SLC35A2 variants fall into two categories: (i) germline or de novo mutations, which give rise to SLC35A2-CDG and result in widespread neurodevelopmental impairment, and (ii) somatic, brain-restricted mutations, which underlie focal cortical malformations such as MOGHE and non-lesional focal epilepsies.